Recently, various executives have taken part in insider trading activity for the stocks of Skyworks Solutions Inc (NASDAQ:SWKS), Palo Alto Networks Inc (NYSE:PANW), Celldex Therapeutics, Inc. (NASDAQ:CLDX), and Rockwell Medical Inc (NASDAQ:RMTI).

Skyworks Solutions Inc

CEO David Aldrich unloaded 10,000 Skyworks Solutions shares (6.25% of total stake), valued at $903,000, in a transaction dated August 11. The shares were sold via automatic sale program. Aldrich now holds directly and indirectly 150,091 of the company’s shares that are valued at $13,553,217.

EVP of Worldwide Operations Bruce Freyman sold 8,000 shares (19.62% of total stake), valued at $720,000, on August 10. The shares were sold via automatic sale program. Freyman now holds 32,776 of the company’s shares that are valued at $2,918,375.

Click Here to see the performance of Skyworks Solutions insiders.

Palo Alto Networks Inc

President and CEO Mark Mclaughlin unloaded 25,000 Palo Alto Networks shares (3.58% of total stake), valued at $4,359,415, in multiple transactions dated August 11. The shares were sold via automatic sale program. Mclaughlin now holds 698,789 of the company’s shares that are valued at $120,023,999.

CTO Nir Zuk disposed of 30,000 shares (1.38% of total stake), valued at $5,195,162, in six transactions on August 7. The shares were sold via automatic sale program. Zuk now holds 2,149,673 of the company’s shares that are valued at $369,227,834.

Click Here to see the performance of Palo Alto Networks insiders.

Celldex Therapeutics, Inc.

President and Ceo Anthony Marucci bought 5,800 Celldex shares worth $97,440 at an average price of $16.80, as reported in the SEC filing yesterday. Following the insider-buying transaction, his stake in Celldex has now grown to 50,028 shares with a value of $838,970.

Director Larry Ellberger purchased yesterday 5,000 shares, valued at $82,950. After completion of the transaction, Ellberger owns 38,500 shares, worth $645,645.

Click Here to see the performance of Celldex Therapeutics insiders.

Rockwell Medical Inc

Chairman, President and CEO Robert Chioini yesterday purchased 5,090 Rockwell shares, valued at $58,597. After completion of the transaction, Chioini owns 1,789,023 shares, worth $20,627,435.

Chief Scientific Ajay Gupta bought yesterday 5,000 shares worth $58,112 at an average price of $11.62. Following the insider-buying transaction, his stake in Rockwell has now grown to 326,667 shares with a value of $3,766,471.

Click Here to see the performance of Rockwell Medical insiders.